Celldex Therapeutics | CLDX - 当期純利益





当期純利益 変化する 日付
AbbVie USD 695M 1.12B 2026-03
Agenus USD -10.63M 74.49M 2025-12
Amgen USD 1.82B 486M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Celldex Therapeutics USD -78.68M 2.63M 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Northwest Biotherapeutics USD -27.18M 7.81M 2025-09
Pfizer USD 2.69B 4.34B 2026-03
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Roche Holding CHF 5.47B 1.76B 2025-12